CNB Bank’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-3,050
Closed -$15K 446
2020
Q4
$15K Hold
3,050
0.01% 295
2020
Q3
$18K Hold
3,050
0.02% 278
2020
Q2
$21K Buy
3,050
+1,900
+165% +$14.4K 0.02% 278
2020
Q1
$7K Hold
1,150
0.01% 324
2019
Q4
$12K Buy
+1,150
New +$8.36K 0.01% 315

Other funds holding CLVS

CNB Bank's CLVS Position: Q1 2021 in Review

CNB Bank sold out of Clovis Oncology, Inc. (CLVS) in Q1 2021, closing a stake of 3,050 shares — an estimated $15K sold.

CNB Bank first reported a position in CLVS in Q4 2019 and held it in 5 quarters. The position peaked at $21K in Q2 2020. 165 funds tracked by Wall St. Rank hold CLVS as of Q1 2021.

  • CNB Bank reported no remaining Clovis Oncology, Inc. position as of Q1 2021 after selling out during the quarter.
  • CNB Bank sold 3,050 Clovis Oncology, Inc. shares in Q1 2021, an estimated $15K.
  • CNB Bank first reported a position in Clovis Oncology, Inc. in Q4 2019 and held it in 5 quarters.
  • CNB Bank's Clovis Oncology, Inc. position peaked at $21K in Q2 2020.
  • 165 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2021.

Based on CNB Bank's 13F filing for Q1 2021, filed 3 May 2021.